Quick Search  in all journalsin this journalin this issue Journals Home Drugs of the Future Issues Drugs of the Future Policies & Guidelines Permissions My Profile Contact Us Shopping Cart Purchase History

	Drugs of the Future		Register or sign in
	Drugs Fut 2005, 30(2): 161 ISSN 0377-8282 e-ISSN 2013-0368 Copyright 2005 Clarivate CCC: 0377-8282 DOI: 10.1358/dof.2005.030.02.869228
	Organic carbamates in drug development. Part II: antimicrobial agents - Recent reports Ray, S., Pathak, S.R., Chaturvedi, D.
	The continuous evolution of new microbes that are resistant to available antimicrobial agents poses a serious problem in the medical world and presents a challenge for the development of newer agents with a broadened spectrum of activity and improved pharmacological and pharmacokinetic properties. In this area, a number of organic carbamates have emerged in the recent past as potential antibacterial and antiviral agents. The carbamate residue present in such molecules either contributes as a core component or towards improvement of their pharmacological and pharmacokinetic properties. Such compounds include both natural and synthetic products. In this review, recent data on carbamate antibacterial and antiviral agents are discussed. Full Text: HTML, PDF

	© Clarivate. All rights reserved.
	Copyright Notice	Terms of Use	Privacy Statement	Cookie Policy	Manage cookie preferences